Inspection of various molecular pathways associated with ependymomas may establish the foundation for developing novel therapies capable of achieving significant clinical improvements with individualized regimens specifically designed for personalized treatment strategies.
Therefore, a thorough identification and characterisation of the main energy consumption processes may lay the foundation for developing novel mechanisms aimed to make a more efficient use of devices' batteries, as well as for planning future network deployments.
Therefore, the knowledge we have gained on how capsaicin activates this channel may lay the foundation for developing novel analgesics targeting TRPV1 without adverse effects.
Thus, the observed methylation differences of disease-associated genes between placental tissue and maternal peripheral blood provide a foundation for developing novel methods for the detection of fetal genes in maternal peripheral blood.
Connecting signalling pathways and epigenetic modifications that regulate cell proliferation, survival, and myogenic differentiation will be key in fully understanding the cell biology of RMS, which will provide the foundation for developing novel therapeutic strategies for RMS treatment.
Chemical proteomics is now widely applied to identify possible targets of kinase inhibitors through affinity purification from cellular extracts, resulting in the identification of the whole spectrum of potential drug targets and providing a strong foundation for developing novel potent drugs that exert no side effects.
These results suggest that combination of CAERS and CFEZO provides a useful foundation for studying and developing novel chemotherapeutic agents for the treatment of GBM.
These discoveries provide a foundation for future studies that will take the next steps towards fully understanding TSEs, developing novel genomic based diagnostic assays for TSEs, and identifying targets for drug therapies to treat TSEs.
This work lays the foundation for further studies investigating the feasibility of this strategy for targeting the dimer interface of EGFR and developing novel anti-EGFR drugs.
Together with previous findings, our data demonstrate the critical and complex roles of acetylation in activating human p53 response to DNA damage and could provide the foundation to develop novel strategies to activate p53 in human cancer cells harboring WT but dysfunctional p53.
Our finding that IBC cells are sensitive to HDAC6 inhibition provides a foundation to rapidly develop novel, efficient, and well-tolerated targeted therapy strategies for IBC patients.
